Catalyst Wire Dossier Catalyst Wire Dossier

CD30-CCR4 CAR-T cells

CD30- and CCR4-directed CAR-T cells
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD30-CCR4 CAR-T cells, covering 2026-01-06 to 2026-01-06. Get the full timeline:

Most recent: Clinical Trial Update: Study of CAR-T Cells Expressing CD30 and CCR4 for r/r CD30+ HL and CTCL [Phase 1]

See pricing